Omnihealth Practice

PSYCHIATRY

Optimizing bipolar disorder treatment with antipsychotics and long-acting injectables

25 Mar 2026

Brexpiprazole augmentation achieving remission in MDD with anxiety features during long-term venlafaxine maintenance: A case report

05 Jan 2026

Heartfelt Connections: The Shadow of PND on Maternal CV Health

03 Dec 2024

Case sharing: Brexpiprazole augmentation in MDD patients with anxiety symptoms provides the trifactor of clinical outcomes, patient compliance and functional recovery

13 Mar 2024

A case sharing of early brexpiprazole augmentation to preserve QoL among MDD patients with inadequate response to prior ADT

27 Nov 2023

Overcome the flat dose-response of ssri with venlafaxine

17 Jan 2023

Adopting Telemedicine In The Management of Schizophrenia

03 Jan 2022

Mental incapacity: Prepare and protect while still capable, don’t wait till it is regrettable

28 Feb 2021

Adopting Telemedicine In The Management of Schizophrenia

Despite the increased awareness of schizophrenia in Hong Kong, there remains considerable stigma attached with the illness that prevents patients from receiving the appropriate treatment. A paradigm shift of the healthcare system with telemedicine is the next step to optimizing the management of sch

03 Jan 2022

Dr. Keith Hariman

Specialist in Psychiatry

Mental incapacity: Prepare and protect while still capable, don’t wait till it is regrettable

In routine clinical practice, a treatment decision can only legally proceed after patients are adequately informed and have voluntarily granted their consent for said decision.^1,2 However, in patients whose mental capacity are compromised, a decision made on their behalf from an unauthorized third p

28 Feb 2021

Dr. Leung, Lam-Ming Jess

Honorary Clinical Associate Professor,
Department of Psychiatry,
Faculty of Medicine,
The Chinese University of Hong Kong

EPA 2023

March 25-28, 2023 | Paris, France

Optimizing bipolar disorder treatment with antipsychotics and long-acting injectables

PSYCHIATRY

25 Mar 2026

Dr. Lin, Shih-Ku

Attend Psychiatrist,
Taipei Chang Gung Memorial Hospital,
Taiwan
Vice President, Asian College of
Neuropsychopharmacology (AsCNP)

Dr. Fang, Chun-Kai

Chief,
Hospice and Palliative Care Center,
MacKay Memorial Hospital,
Taiwan

Overcome the flat dose-response of ssri with venlafaxine

This study provided evidence of the possible existence of a dose-response relationship with venlafaxine.

17 Jan 2023

Lancet Psychiatry. 2019.

Furukawa TA, et al. Optimal dose of selective serotonin reuptake inhibitors (SSRIs), venlafaxine, and mirtazapine in major depression: A systematic review and dose-response meta-analysis.

Brexpiprazole augmentation achieving remission in MDD with anxiety features during long-term venlafaxine maintenance: A case report

Major depressive disorder (MDD) remains a challenging psychiatric condition, with nearly half of patients failing to achieve an adequate response to initial antidepressant therapy (ADT).1 Traditional augmentation strategies, including second-generation antipsychotics, may offer symptomatic relief bu

05 Jan 2026

Bridging generations and breaking cycles: Insights into youth mental health

Suicide rates among adolescents and young adults have been on the rise between 2007 and 2024.1 At the Hong Kong International Mental Health Conference 2025, Professor Hung, Se Fong, presented epidemiological data on the high prevalence and risk factors of child and adolescent psychiatric disorders i

10 Dec 2025

HKU study defines serum lithium thresholds for the treatment of bipolar disorder linked to thyroid and renal risk complications

Bipolar disorder (BD) is a chronic condition associated with relapse and elevated suicide risk, for which lithium remains a key maintenance therapy to reduce recurrence, readmission, and self-harm. However, concerns about its renal and thyroid effects persist.

02 Sep 2025

OBSTETRICS & GYNECOLOGY PSYCHIATRY CARDIOLOGY

Heartfelt Connections: The Shadow of PND on Maternal CV Health

03 Dec 2024